Individualized Medicine
October 1, 2026
Mayo Clinic researchers report encouraging early results from an experimental therapy targeting the genetic cause of a rare form of amyotrophic lateral sclerosis, or ALS.
November 5, 2024
October 30, 2024
October 9, 2024
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community